GETI-B:STO
Getinge Group
232,00Â SEK
arrow_downward
−0,22%(−0,50) 1 D
20. juli, 17:29:40 GMT+2 · SEK
search
Alle symboler
1Â D
5Â D
1Â M
6Â M
I år
1Â Ã…
5Â Ã…
MAKS
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for GETI-B …
Ã…pne
231,40Â SEK
Høy
232,00Â SEK
Lav
228,50Â SEK
Markedsverdi
58,96Â mrd.
Snittvolum
552,53k
Volum
583,19k
Utbytte
2,05Â %
Kvartalsvis utbytte
1,19Â SEK
Første dato etter utbytte
22. apr. 2026
P/E-forhold
23,63
52 u høy
232,00Â SEK
52Â u lav
175,90Â SEK
EPS
9,82Â SEK
Utestående aksjer
254,15Â mill.
Antall ansatte
12k
Ã…pne
231,40Â SEK
Høy
232,00Â SEK
Lav
228,50Â SEK
Markedsverdi
58,96Â mrd.
Snittvolum
552,53k
Volum
583,19k
Utbytte
2,05Â %
Kvartalsvis utbytte
1,19Â SEK
Første dato etter utbytte
22. apr. 2026
P/E-forhold
23,63
52 u høy
232,00Â SEK
52Â u lav
175,90Â SEK
EPS
9,82Â SEK
Utestående aksjer
254,15Â mill.
Antall ansatte
12k
Nyhetssaker
Fra kilder på nettet
ad-hoc-news.de
·
for 11 timer siden
Getinge stock trades steady as recent earnings highlight margin and cash flow trends
Seeking Alpha
·
for 3 døgn siden
Getinge AB (publ) 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:GNGBY) 2026-07-17
Profil
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
Om Getinge Group
Administrerende direktørMattias Perjos
Ansatte11,8k
Grunnlagt1904
Hovedkontor-
Sektor-
Nettstedgetinge.com
AI-innhold kan inneholde feil. Finn ut mer